Interparfums, Inc. — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022. The consolidated interim financial statements are unaudited; amounts below are in U.S. dollars unless stated otherwise.
Business context
Interparfums manufactures, markets and distributes prestige fragrances and related products through European and U.S. operations. European operations generated about 70% of first-half sales, compared with 79% in 2021; U.S. operations accounted for about 30%, versus 21%. The business depends substantially on third-party brand licenses.
Financial performance
| Metric | Q2 2022 | Q2 2021 | First half 2022 | First half 2021 |
|---|---|---|---|---|
| Net sales | $244.7 million | $207.6 million | $495.4 million | $406.1 million |
| Sales growth, reported | 18% | — | 22% | — |
| Sales growth, constant currency | 24% | — | 27% | — |
| Gross profit | $153.8 million | $132.4 million | $312.4 million | $257.6 million |
| Consolidated gross margin | 62.8% | 63.8% | 63.1% | 63.4% |
| Operating income | $45.4 million | $44.7 million | $106.6 million | $92.6 million |
| Net income | $34.5 million | $29.0 million | $80.8 million | $65.7 million |
| Net income attributable to Interparfums, Inc. | $27.6 million | $22.7 million | $62.9 million | $50.3 million |
| Diluted EPS | $0.86 | $0.71 | $1.97 | $1.58 |
Operating margin was 18.6% in Q2, down from 21.5%; for the first half it was 21.5%, down from 22.8%. First-half promotion and advertising expense increased to $80.1 million from $55.0 million, or 16.2% of sales from 13.5%. Management expects advertising to be about 21% of full-year sales.
First-half operating cash flow was negative $28.5 million, versus positive $38.1 million a year earlier. Investing cash flow was negative $28.1 million and financing cash flow negative $59.0 million. Cash and cash equivalents fell to $52.2 million from $159.6 million at year-end; short-term investments were $143.6 million. Management reported $196 million in combined cash, cash equivalents and short-term investments, working capital of $445 million, and a working capital ratio of 2.9:1.
At June 30, total debt was $130.7 million, down from $148.8 million at December 31, 2021. Current and long-term lease liabilities totaled $31.4 million. First-half capital expenditures included $24.2 million related to the Paris headquarters. The company declared dividends of $1.00 per share in the first half; its annual dividend authorization had been increased to $2.00 per share.
Changes and drivers versus prior period
- Sales growth was broad-based but uneven: first-half European-based product sales increased 9% as reported (17% in euros), while U.S.-based sales rose 72%. The stronger U.S. dollar reduced reported European growth and sales.
- First-half net income attributable to the company rose 25%, and diluted EPS increased from $1.58 to $1.97. Operating income grew more slowly than sales as advertising, promotion and other SG&A increased.
- Gross margin improved in both segments year over year for the first half, but consolidated gross margin edged down. A stronger dollar supported European margins, partly offset by higher transportation and component costs.
- Working capital absorbed $117.2 million of cash in the first half. Accounts receivable increased 30% and inventory increased 41% from year-end; management cited strong demand and deliberate inventory-building amid supply constraints. Days sales outstanding were 76, compared with 79 in the prior-year period.
- Foreign-currency translation reduced first-half comprehensive income; accumulated other comprehensive loss was $70.4 million at June 30, versus $38.4 million at year-end.
Outlook, commentary and risks
Management described 2022 as exceptionally strong and said growth catalysts outweighed headwinds, but provided no specific full-year sales or earnings guidance in the filing. Planned launches include new products across several brands, and Donna Karan/DKNY licensing became effective July 1, 2022, with new launches planned for 2023.
- Management said supply-chain bottlenecks were not expected to begin easing until later in 2022. Component procurement, transport disruptions and related cost increases could weigh on sales and margins; the filing warns COVID-19 effects could materially adversely affect results, financial position and cash flows through at least year-end 2022.
- COVID-related restrictions and reduced international travel remained risks, although travel retail was beginning to recover. The Russia-Ukraine conflict and related sanctions were described as uncertain; those activities had no material financial-statement impact in the first half. The company reported Russia and Ukraine represented about 4% of 2021 consolidated sales and did not expect material credit losses, citing insurance or advance payment.
- Currency movements affect reported sales and margins. The company uses foreign-exchange forwards; at June 30 it had contracts of approximately $103 million and £3 million, all maturing within one year.
- Short-term investments included $16.8 million of luxury-sector marketable equity securities. These generated losses of about $2.5 million in Q2 and $5.9 million in the first half.
- The Paris headquarters was financed partly by a 10-year €120 million loan at one-month Euribor plus 0.75%; about €80 million of variable-rate debt was hedged with a swap limiting the rate to 2%.
Important facts for investors to verify
- Whether inventory growth converts to sales and cash, and whether supply and logistics constraints ease as management expected.
- How advertising spending, higher operating expenses and cost pressures affect margins as sales expand.
- Brand-license concentration, renewal terms, minimum royalty and advertising commitments, and the contribution of recently added licenses.
- Liquidity and debt exposure, including the effect of Euribor changes on the unhedged portion of the Paris loan.
- Foreign-exchange effects and potential volatility from the luxury-sector equity investments.
- Management’s qualitative optimism against the absence of quantified full-year revenue or earnings guidance.